M&A Deal Summary |
|
---|---|
Date | 2006-01-24 |
Target | 3F Therapeutics |
Sector | Medical Products |
Buyer(s) | ATS Medical |
Deal Type | Add-on Acquisition |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1992 |
Sector | Medical Products |
Employees | 245 |
ATS Medical, Inc., engages in the development, manufacture and marketing of medical devices for the treatment of structural heart diseases. It offers prosthetic heart valves, such as ATS Open Pivot Heart Valve, as well as ATS 3F Aortic Bioprosthesis, a biological replacement aortic heart valve and heart valve repair products. The company also markets and sells surgical cryoablation products for the treatment of cardiac arrhythmias, and it is developing minimally invasive and off-pump aortic valve concepts.
DEAL STATS | # |
---|---|
Overall | 1 of 2 |
Sector (Medical Products) | 1 of 1 |
Type (Add-on Acquisition) | 1 of 1 |
State (California) | 1 of 1 |
Country (United States) | 1 of 1 |
Year (2006) | 1 of 1 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2007-06-28 |
CryoCath - Surgical Ablation Business
Canada CryoCath - Surgical Ablation Business is a provider allograft tissue services, and the development of PARSUS blood filtration technology. |
Buy | - |